Welcome to CREANT!

CREANT is the acronym of the Center for Radiopharmaceuticals Antwerp.

What we do

We create innovative radiopharmaceutical solutions that will improve the lives of cancer patients around the globe.

Discover our research

Our mission

CREANT’s mission is to ensure that the right cancer treatment is given to the right patient at the right time. By developing radiopharmaceuticals that target specific cancer markers we aim to provide an individually tailored therapeutic intervention.

Meet the team

CREANT is driven by the enthousiasm of a large number of people.

Meet the team


Creating innovative radiopharmaceuticals for tomorrow’s theranostics.


No open vacancies at this time

We currently do not have open vacancies. However, you can make an open application for the role you want at any time by contacting us.



Our team has developed a novel immuno-PET imaging tool that can help tailoring cancer therapies. Check out our latest publication.



The European medical isotope programme – PRISMAP – has launched. This consortium aims to fast-track nuclear medicine research. Check the website!


Our partners

University of Antwerp
Molecular Imaging Center Antwerp (MICA)
Antwerp University Hospital (UZA)